Pricing Log in Create free account

Valneva SE Sponsored ADR (VALN) vs VectivBio Holding AG (VECT)

Valneva SE Sponsored ADR and VectivBio Holding AG are both Biotechnology companies. Valneva SE Sponsored ADR and VectivBio Holding AG are of similar size ($560.4M and $545.5M). VectivBio Holding AG has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 59.7×. VectivBio Holding AG has the higher net margin (0.00% vs −12.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Valneva SE Sponsored ADR leads on 5 and VectivBio Holding AG on 5.

Valuation

Metric VALN VECT Biotechnology median
P/E 59.68 n/m 8.50
P/S 3.05 n/m 9.71
P/B 5.30 3.94 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 42.91 n/m 0.64
EV/Sales 3.49 n/m 9.21
Earnings yield 1.68% (27.42%) (33.15%)
Free cash flow yield (11.78%) (21.00%) (25.50%)

Profitability

Metric VALN VECT Biotechnology median
Gross margin 38.28% — 65.16%
Operating margin 13.56% — 0.00%
Net margin (12.01%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (147.18%) (56.36%)
Return on assets 0.00% (111.86%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric VALN VECT Biotechnology median
Revenue growth (TTM) (53.16%) — 6.02%
EPS growth (last fiscal year) (805.88%) 34.37% 30.26%
Revenue growth, 5-year CAGR 9.41% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric VALN VECT Biotechnology median
Debt to equity 2.27 0.05 0.00
Current ratio 2.16 9.14 4.72
Net debt to EBITDA (1.15) 2.63 0.96

Dividend

Metric VALN VECT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric VALN VECT Biotechnology median
Market cap 560.39m 545.50m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack